In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...
World Politics Review on MSN
A Landmark Deal on HIV Prevention
Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...
Gilead drug deal opens door for $40-a-year generic version of groundbreaking HIV prevention overseas
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...
The Print on MSN
HIV prevention jab in India soon at fraction of US cost? 2 drugmakers set to roll out generics
Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...
allAfrica.com on MSN
Cheaper HIV prevention drug coming
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...
A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community ...
The Punch on MSN
N70,000 HIV prevention injection splits Nigerians
A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in ...
Over 100 low-income countries are expected to have access to a new HIV prevention drug within two years, potentially bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results